Companies
(73)
AAC Clyde Space
ALM Equity
Alzinova
Arion Bank
Arlandastad Group
Ascelia Pharma
Bactiguard
Bergman & Beving
Besqab
BioPorto
Björn Borg
Bokusgruppen
Bonava
BTS Group
Byggmästaren
CAG Group
Calviks
Carasent
CDON
Clavister
Clemondo Group
eEducation Albert
Elanders
Elicera Therapeutics
Eolus
Ependion
EQL Pharma
Faron Pharmaceuticals
FluoGuide
Gentoo Media
GiG Software
HAKI Safety
HANZA
Iconovo
Idun Industrier
InfraCom
Initiator Pharma
Intervacc
ITAB Group
Kebni
Lifecare ASA
Lindex Group
Logistri
Lumi Education Group
Lytix Biopharma
Medivir
Mentice
Micro Systemation
MilDef Group
Net Insight
Nordic LEVEL Group
Orexo
Ortoma
OssDsign
Paxman
Pierce
PowerCell
Pricer
Qualisys
Relais Group
SaltX
Scanfil
Sensys Gatso Group
Sleep Cycle
Solar Foods
Spago Nanomedical
Svedbergs Group
Taaleri
Terranor
Vertiseit
Vivesto
W5 Solutions
Waystream
Sweden
Real Estate
Near term
6-12 MONTHS
We expect Arlandastad Group to demonstrate continued value realisation from its building rights portfolio, supported by an elevated development tempo and active JV structures. The introduction of a dividend framework shifts focus toward repeatable monetisation of projects and disciplined capital allocation. Near-term progress in key development clusters and operational efficiency initiatives should support improving earnings quality and cash flow visibility. The balance sheet remains conservative, providing flexibility to execute transactions while maintaining financial stability.
Long term
6+ YEARS
Structural infrastructure investments and improved connectivity are expected to strengthen demand across Arlandastad Group’s development areas. With one of Sweden’s largest portfolios of building rights, the company retains significant optionality to phase projects in line with market conditions. The combination of long-duration land exposure, cluster development strategy and capital discipline supports sustained value creation over time. Continued focus on sustainable development and energy-efficient solutions enhances the long-term attractiveness of the portfolio.
Slower transaction markets or reduced investor appetite could delay land monetisation and pressure dividend sustainability.
Execution risk in advancing projects, securing partners or converting planning progress into realised transactions.
Macroeconomic volatility, including interest rate movements, may impact tenant demand, valuation levels and financing conditions.
Regulatory or planning delays could extend project timelines and increase development costs.
Price
Fair range high value
Fair range low value
For the low end of our fair value range, we apply a 20% discount to the market value of the building rights portfolio. This reflects the assumption that Arlandastad Group will fully develop its building rights rather than divesting portions of its land bank. The discount reflects long-term risks, including market uncertainties and extended project timelines. For the upper end, we apply a 10% premium to the building rights portfolio’s market value. This is based on recent transactions, which indicate that the company has successfully sold building rights at significantly higher prices per square metre than their book value. In this scenario, the company strategically divests parts of its portfolio over time, realising higher valuations than its book value.
Arlandastad Group is a property development company focused on large-scale, infrastructure-linked land areas. The group operates across property development, property management and selected operating businesses, with a strategy centred on value creation through planning, leasing, joint ventures and land sales. The company controls two of Sweden’s largest development clusters: Explore Arlandastad, located adjacent to Stockholm Arlanda Airport, and Explore Skavsta, including Stockholm Skavsta Airport. Together, these areas provide substantial long-term building rights exposure and phased development optionality.
About DNB Carnegie Access
DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.
Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.
Private Banking
Tailored wealth management. Your financial future, personalized.
Montrose
A digital investment platform designed for passionate investors.
DNB Carnegie
Leading Nordic investment bank and wealth management.
© Copyright DNB Carnegie Investment Bank AB